nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—Flutamide—prostate cancer	0.314	0.541	CrCtD
Nitisinone—Nilutamide—prostate cancer	0.267	0.46	CrCtD
Nitisinone—Flutamide—Nilutamide—prostate cancer	0.18	0.54	CrCrCtD
Nitisinone—Nilutamide—Flutamide—prostate cancer	0.153	0.459	CrCrCtD
Nitisinone—HPD—prostate gland—prostate cancer	0.00649	0.471	CbGeAlD
Nitisinone—HPD—renal system—prostate cancer	0.00443	0.321	CbGeAlD
Nitisinone—HPD—testis—prostate cancer	0.00286	0.208	CbGeAlD
Nitisinone—HPD—Amino acid and derivative metabolism—HAO1—prostate cancer	0.00156	0.0639	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—CSAD—prostate cancer	0.00127	0.0521	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—ADI1—prostate cancer	0.00127	0.0521	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—TST—prostate cancer	0.00127	0.0521	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—PSAT1—prostate cancer	0.00127	0.0521	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—GRHPR—prostate cancer	0.00118	0.0484	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—CKMT2—prostate cancer	0.00118	0.0484	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—MTAP—prostate cancer	0.00082	0.0336	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—ARG2—prostate cancer	0.000731	0.0299	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—PHGDH—prostate cancer	0.000731	0.0299	CbGpPWpGaD
Nitisinone—Flutamide—AHR—prostate cancer	0.000514	0.239	CrCbGaD
Nitisinone—HPD—Amino acid and derivative metabolism—SLC5A5—prostate cancer	0.000386	0.0158	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—NQO1—prostate cancer	0.000372	0.0152	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—TH—prostate cancer	0.000367	0.015	CbGpPWpGaD
Nitisinone—Flutamide—CYP1B1—prostate cancer	0.000295	0.137	CrCbGaD
Nitisinone—HPD—Metabolism—HAO1—prostate cancer	0.000287	0.0117	CbGpPWpGaD
Nitisinone—Nilutamide—AR—prostate cancer	0.000265	0.123	CrCbGaD
Nitisinone—Flutamide—AR—prostate cancer	0.000259	0.12	CrCbGaD
Nitisinone—Flutamide—CYP3A5—prostate cancer	0.000235	0.109	CrCbGaD
Nitisinone—HPD—Metabolism—CBR1—prostate cancer	0.000234	0.00956	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CSAD—prostate cancer	0.000234	0.00956	CbGpPWpGaD
Nitisinone—HPD—Metabolism—TST—prostate cancer	0.000234	0.00956	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PSAT1—prostate cancer	0.000234	0.00956	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ADI1—prostate cancer	0.000234	0.00956	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GRHL1—prostate cancer	0.000234	0.00956	CbGpPWpGaD
Nitisinone—HPD—Metabolism—UGT2B15—prostate cancer	0.000217	0.00889	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CKMT2—prostate cancer	0.000217	0.00889	CbGpPWpGaD
Nitisinone—HPD—Metabolism—UGT2B17—prostate cancer	0.000217	0.00889	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GRHPR—prostate cancer	0.000217	0.00889	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PGAM2—prostate cancer	0.000204	0.00836	CbGpPWpGaD
Nitisinone—HPD—Metabolism—NAGLU—prostate cancer	0.000204	0.00836	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTM3—prostate cancer	0.000204	0.00836	CbGpPWpGaD
Nitisinone—HPD—Metabolism—AOX1—prostate cancer	0.000204	0.00836	CbGpPWpGaD
Nitisinone—HPD—Metabolism—RFK—prostate cancer	0.000204	0.00836	CbGpPWpGaD
Nitisinone—HPD—Metabolism—MBTPS1—prostate cancer	0.000204	0.00836	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SULT2B1—prostate cancer	0.000204	0.00836	CbGpPWpGaD
Nitisinone—HPD—Metabolism—AMACR—prostate cancer	0.000194	0.00792	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CYP3A43—prostate cancer	0.000194	0.00792	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SRD5A2—prostate cancer	0.000194	0.00792	CbGpPWpGaD
Nitisinone—HPD—Metabolism—DEGS1—prostate cancer	0.000194	0.00792	CbGpPWpGaD
Nitisinone—HPD—Metabolism—NAT1—prostate cancer	0.000194	0.00792	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HSD17B1—prostate cancer	0.000185	0.00756	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HPGD—prostate cancer	0.000165	0.00674	CbGpPWpGaD
Nitisinone—HPD—Metabolism—B4GALT4—prostate cancer	0.000165	0.00674	CbGpPWpGaD
Nitisinone—Nilutamide—CYP2C19—prostate cancer	0.000164	0.0762	CrCbGaD
Nitisinone—Flutamide—CYP2C19—prostate cancer	0.00016	0.0743	CrCbGaD
Nitisinone—Flutamide—CYP1A1—prostate cancer	0.000159	0.074	CrCbGaD
Nitisinone—HPD—Metabolism—TNFRSF21—prostate cancer	0.000155	0.00633	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CYP7B1—prostate cancer	0.000151	0.00616	CbGpPWpGaD
Nitisinone—HPD—Metabolism—MTAP—prostate cancer	0.000151	0.00616	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SULT1E1—prostate cancer	0.000147	0.006	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SRD5A1—prostate cancer	0.000147	0.006	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ACSL4—prostate cancer	0.00014	0.00573	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HSD17B3—prostate cancer	0.00014	0.00573	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ARG2—prostate cancer	0.000134	0.00549	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PHGDH—prostate cancer	0.000134	0.00549	CbGpPWpGaD
Nitisinone—HPD—Metabolism—UMPS—prostate cancer	0.000134	0.00549	CbGpPWpGaD
Nitisinone—HPD—Metabolism—LDHB—prostate cancer	0.000132	0.00539	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CYP3A5—prostate cancer	0.000129	0.00529	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PDHA1—prostate cancer	0.000125	0.00511	CbGpPWpGaD
Nitisinone—HPD—Metabolism—TCN2—prostate cancer	0.000125	0.00511	CbGpPWpGaD
Nitisinone—HPD—Metabolism—UCP3—prostate cancer	0.000125	0.00511	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTA3—prostate cancer	0.000125	0.00511	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SLC22A3—prostate cancer	0.000119	0.00487	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HSD3B1—prostate cancer	0.000119	0.00487	CbGpPWpGaD
Nitisinone—HPD—Metabolism—TBXAS1—prostate cancer	0.000114	0.00467	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTA4—prostate cancer	0.000114	0.00467	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTA2—prostate cancer	0.000111	0.00455	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ABCG5—prostate cancer	0.00011	0.00449	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SULT1A1—prostate cancer	0.00011	0.00449	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTA1—prostate cancer	0.000107	0.00439	CbGpPWpGaD
Nitisinone—HPD—Metabolism—HSD3B2—prostate cancer	0.000106	0.00434	CbGpPWpGaD
Nitisinone—HPD—Metabolism—NAT2—prostate cancer	0.000106	0.00434	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTO1—prostate cancer	0.000106	0.00434	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PLCB2—prostate cancer	0.000102	0.00416	CbGpPWpGaD
Nitisinone—HPD—Metabolism—LRP2—prostate cancer	0.000102	0.00416	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CYP2C18—prostate cancer	0.000102	0.00416	CbGpPWpGaD
Nitisinone—Flutamide—CYP3A4—prostate cancer	0.000102	0.0472	CrCbGaD
Nitisinone—HPD—Metabolism—P4HB—prostate cancer	9.98e-05	0.00408	CbGpPWpGaD
Nitisinone—Eye disorder—Goserelin—prostate cancer	9.93e-05	0.00211	CcSEcCtD
Nitisinone—Leukocytosis—Prednisone—prostate cancer	9.91e-05	0.00211	CcSEcCtD
Nitisinone—Eye disorder—Conjugated Estrogens—prostate cancer	9.83e-05	0.00209	CcSEcCtD
Nitisinone—Cataract—Prednisone—prostate cancer	9.79e-05	0.00208	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC22A1—prostate cancer	9.7e-05	0.00397	CbGpPWpGaD
Nitisinone—Somnolence—Bicalutamide—prostate cancer	9.64e-05	0.00205	CcSEcCtD
Nitisinone—Hepatomegaly—Doxorubicin—prostate cancer	9.52e-05	0.00202	CcSEcCtD
Nitisinone—Rash erythematous—Epirubicin—prostate cancer	9.51e-05	0.00202	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	9.5e-05	0.00202	CcSEcCtD
Nitisinone—Pruritus—Degarelix—prostate cancer	9.5e-05	0.00202	CcSEcCtD
Nitisinone—HPD—Metabolism—SULT2A1—prostate cancer	9.46e-05	0.00387	CbGpPWpGaD
Nitisinone—Headache—Nilutamide—prostate cancer	9.41e-05	0.002	CcSEcCtD
Nitisinone—Alopecia—Goserelin—prostate cancer	9.39e-05	0.00199	CcSEcCtD
Nitisinone—Sepsis—Docetaxel—prostate cancer	9.37e-05	0.00199	CcSEcCtD
Nitisinone—Headache—Flutamide—prostate cancer	9.37e-05	0.00199	CcSEcCtD
Nitisinone—HPD—Metabolism—MED12—prostate cancer	9.3e-05	0.00381	CbGpPWpGaD
Nitisinone—Alopecia—Conjugated Estrogens—prostate cancer	9.3e-05	0.00197	CcSEcCtD
Nitisinone—HPD—Metabolism—GNG5—prostate cancer	9.23e-05	0.00378	CbGpPWpGaD
Nitisinone—Diarrhoea—Degarelix—prostate cancer	9.19e-05	0.00195	CcSEcCtD
Nitisinone—Conjunctivitis—Estradiol—prostate cancer	9.12e-05	0.00194	CcSEcCtD
Nitisinone—Infection—Ethinyl Estradiol—prostate cancer	9.11e-05	0.00193	CcSEcCtD
Nitisinone—Sepsis—Capecitabine—prostate cancer	9.07e-05	0.00193	CcSEcCtD
Nitisinone—Tension—Goserelin—prostate cancer	9.07e-05	0.00193	CcSEcCtD
Nitisinone—Tension—Conjugated Estrogens—prostate cancer	8.99e-05	0.00191	CcSEcCtD
Nitisinone—Nervousness—Goserelin—prostate cancer	8.98e-05	0.00191	CcSEcCtD
Nitisinone—Skin disorder—Ethinyl Estradiol—prostate cancer	8.91e-05	0.00189	CcSEcCtD
Nitisinone—Nervousness—Conjugated Estrogens—prostate cancer	8.9e-05	0.00189	CcSEcCtD
Nitisinone—HPD—Metabolism—NCOA3—prostate cancer	8.89e-05	0.00364	CbGpPWpGaD
Nitisinone—Gastrointestinal pain—Bicalutamide—prostate cancer	8.87e-05	0.00188	CcSEcCtD
Nitisinone—Epistaxis—Estradiol—prostate cancer	8.85e-05	0.00188	CcSEcCtD
Nitisinone—Headache—Estradiol valerate/Dienogest—prostate cancer	8.85e-05	0.00188	CcSEcCtD
Nitisinone—Rash erythematous—Doxorubicin—prostate cancer	8.8e-05	0.00187	CcSEcCtD
Nitisinone—Hepatic failure—Docetaxel—prostate cancer	8.72e-05	0.00185	CcSEcCtD
Nitisinone—Hepatic function abnormal—Capecitabine—prostate cancer	8.69e-05	0.00184	CcSEcCtD
Nitisinone—Diarrhoea—Cabazitaxel—prostate cancer	8.65e-05	0.00184	CcSEcCtD
Nitisinone—Abdominal pain—Bicalutamide—prostate cancer	8.58e-05	0.00182	CcSEcCtD
Nitisinone—Gastroenteritis—Capecitabine—prostate cancer	8.56e-05	0.00182	CcSEcCtD
Nitisinone—Neoplasm malignant—Epirubicin—prostate cancer	8.53e-05	0.00181	CcSEcCtD
Nitisinone—Conjunctivitis—Mitoxantrone—prostate cancer	8.5e-05	0.0018	CcSEcCtD
Nitisinone—HPD—Metabolism—HPGDS—prostate cancer	8.48e-05	0.00347	CbGpPWpGaD
Nitisinone—Haemoglobin—Estradiol—prostate cancer	8.46e-05	0.0018	CcSEcCtD
Nitisinone—Hepatic failure—Capecitabine—prostate cancer	8.45e-05	0.00179	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP2C19—prostate cancer	8.43e-05	0.00345	CbGpPWpGaD
Nitisinone—Haemorrhage—Estradiol—prostate cancer	8.42e-05	0.00179	CcSEcCtD
Nitisinone—Headache—Degarelix—prostate cancer	8.41e-05	0.00179	CcSEcCtD
Nitisinone—Eye pain—Capecitabine—prostate cancer	8.41e-05	0.00179	CcSEcCtD
Nitisinone—Amenorrhoea—Epirubicin—prostate cancer	8.29e-05	0.00176	CcSEcCtD
Nitisinone—Leukopenia—Goserelin—prostate cancer	8.28e-05	0.00176	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTT1—prostate cancer	8.23e-05	0.00337	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ACHE—prostate cancer	8.23e-05	0.00337	CbGpPWpGaD
Nitisinone—Agranulocytosis—Mitoxantrone—prostate cancer	8.16e-05	0.00173	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP2A6—prostate cancer	8.13e-05	0.00333	CbGpPWpGaD
Nitisinone—Hyperkinesia—Prednisone—prostate cancer	8.12e-05	0.00173	CcSEcCtD
Nitisinone—Sepsis—Prednisone—prostate cancer	8.08e-05	0.00172	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Capecitabine—prostate cancer	8.04e-05	0.00171	CcSEcCtD
Nitisinone—Convulsion—Goserelin—prostate cancer	8.01e-05	0.0017	CcSEcCtD
Nitisinone—Thirst—Capecitabine—prostate cancer	7.98e-05	0.00169	CcSEcCtD
Nitisinone—Convulsion—Conjugated Estrogens—prostate cancer	7.94e-05	0.00169	CcSEcCtD
Nitisinone—Headache—Cabazitaxel—prostate cancer	7.92e-05	0.00168	CcSEcCtD
Nitisinone—HPD—Metabolism—AKR1C3—prostate cancer	7.91e-05	0.00324	CbGpPWpGaD
Nitisinone—Neoplasm malignant—Doxorubicin—prostate cancer	7.89e-05	0.00168	CcSEcCtD
Nitisinone—Haemoglobin—Mitoxantrone—prostate cancer	7.89e-05	0.00167	CcSEcCtD
Nitisinone—Eye disorder—Estradiol—prostate cancer	7.87e-05	0.00167	CcSEcCtD
Nitisinone—HPD—Metabolism—PRKACB—prostate cancer	7.87e-05	0.00322	CbGpPWpGaD
Nitisinone—Haemorrhage—Mitoxantrone—prostate cancer	7.85e-05	0.00167	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Docetaxel—prostate cancer	7.84e-05	0.00167	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	7.82e-05	0.00166	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP17A1—prostate cancer	7.79e-05	0.00319	CbGpPWpGaD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	7.74e-05	0.00164	CcSEcCtD
Nitisinone—Pruritus—Bicalutamide—prostate cancer	7.68e-05	0.00163	CcSEcCtD
Nitisinone—Amenorrhoea—Doxorubicin—prostate cancer	7.67e-05	0.00163	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Capecitabine—prostate cancer	7.59e-05	0.00161	CcSEcCtD
Nitisinone—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	7.5e-05	0.00159	CcSEcCtD
Nitisinone—Infection—Goserelin—prostate cancer	7.5e-05	0.00159	CcSEcCtD
Nitisinone—Alopecia—Estradiol—prostate cancer	7.44e-05	0.00158	CcSEcCtD
Nitisinone—Infection—Conjugated Estrogens—prostate cancer	7.43e-05	0.00158	CcSEcCtD
Nitisinone—Diarrhoea—Bicalutamide—prostate cancer	7.42e-05	0.00158	CcSEcCtD
Nitisinone—HPD—Metabolism—NCOA2—prostate cancer	7.42e-05	0.00304	CbGpPWpGaD
Nitisinone—Thrombocytopenia—Goserelin—prostate cancer	7.39e-05	0.00157	CcSEcCtD
Nitisinone—Skin disorder—Goserelin—prostate cancer	7.33e-05	0.00156	CcSEcCtD
Nitisinone—Dehydration—Docetaxel—prostate cancer	7.29e-05	0.00155	CcSEcCtD
Nitisinone—Skin disorder—Conjugated Estrogens—prostate cancer	7.26e-05	0.00154	CcSEcCtD
Nitisinone—Abdominal pain—Ethinyl Estradiol—prostate cancer	7.25e-05	0.00154	CcSEcCtD
Nitisinone—Tension—Estradiol—prostate cancer	7.19e-05	0.00153	CcSEcCtD
Nitisinone—Dry skin—Docetaxel—prostate cancer	7.19e-05	0.00153	CcSEcCtD
Nitisinone—Nervousness—Estradiol—prostate cancer	7.12e-05	0.00151	CcSEcCtD
Nitisinone—Melaena—Epirubicin—prostate cancer	7.12e-05	0.00151	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC5A5—prostate cancer	7.08e-05	0.0029	CbGpPWpGaD
Nitisinone—Dehydration—Capecitabine—prostate cancer	7.06e-05	0.0015	CcSEcCtD
Nitisinone—Dry skin—Capecitabine—prostate cancer	6.96e-05	0.00148	CcSEcCtD
Nitisinone—Alopecia—Mitoxantrone—prostate cancer	6.93e-05	0.00147	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP2E1—prostate cancer	6.91e-05	0.00283	CbGpPWpGaD
Nitisinone—HPD—Metabolism—NQO1—prostate cancer	6.84e-05	0.0028	CbGpPWpGaD
Nitisinone—Headache—Bicalutamide—prostate cancer	6.8e-05	0.00144	CcSEcCtD
Nitisinone—Agranulocytosis—Etoposide—prostate cancer	6.78e-05	0.00144	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Prednisone—prostate cancer	6.76e-05	0.00144	CcSEcCtD
Nitisinone—HPD—Metabolism—TH—prostate cancer	6.74e-05	0.00276	CbGpPWpGaD
Nitisinone—Agitation—Estradiol—prostate cancer	6.74e-05	0.00143	CcSEcCtD
Nitisinone—Gastritis—Capecitabine—prostate cancer	6.72e-05	0.00143	CcSEcCtD
Nitisinone—Somnolence—Goserelin—prostate cancer	6.71e-05	0.00142	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP3A4—prostate cancer	6.67e-05	0.00273	CbGpPWpGaD
Nitisinone—Somnolence—Conjugated Estrogens—prostate cancer	6.65e-05	0.00141	CcSEcCtD
Nitisinone—Rash maculo-papular—Epirubicin—prostate cancer	6.62e-05	0.00141	CcSEcCtD
Nitisinone—Melaena—Doxorubicin—prostate cancer	6.58e-05	0.0014	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP1B1—prostate cancer	6.55e-05	0.00268	CbGpPWpGaD
Nitisinone—Pruritus—Ethinyl Estradiol—prostate cancer	6.49e-05	0.00138	CcSEcCtD
Nitisinone—HPD—Metabolism—GGT1—prostate cancer	6.35e-05	0.0026	CbGpPWpGaD
Nitisinone—Sepsis—Epirubicin—prostate cancer	6.32e-05	0.00134	CcSEcCtD
Nitisinone—Bronchitis—Capecitabine—prostate cancer	6.31e-05	0.00134	CcSEcCtD
Nitisinone—Diarrhoea—Ethinyl Estradiol—prostate cancer	6.27e-05	0.00133	CcSEcCtD
Nitisinone—HPD—Metabolism—NCOA1—prostate cancer	6.25e-05	0.00256	CbGpPWpGaD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	6.2e-05	0.00132	CcSEcCtD
Nitisinone—Dry skin—Prednisone—prostate cancer	6.2e-05	0.00132	CcSEcCtD
Nitisinone—Gastrointestinal pain—Goserelin—prostate cancer	6.17e-05	0.00131	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP19A1—prostate cancer	6.16e-05	0.00252	CbGpPWpGaD
Nitisinone—Rash maculo-papular—Doxorubicin—prostate cancer	6.13e-05	0.0013	CcSEcCtD
Nitisinone—Leukopenia—Mitoxantrone—prostate cancer	6.11e-05	0.0013	CcSEcCtD
Nitisinone—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	6.11e-05	0.0013	CcSEcCtD
Nitisinone—Eye disorder—Etoposide—prostate cancer	6.1e-05	0.0013	CcSEcCtD
Nitisinone—Hepatic function abnormal—Epirubicin—prostate cancer	6.05e-05	0.00129	CcSEcCtD
Nitisinone—Abdominal pain—Goserelin—prostate cancer	5.97e-05	0.00127	CcSEcCtD
Nitisinone—HPD—Metabolism—RXRA—prostate cancer	5.95e-05	0.00243	CbGpPWpGaD
Nitisinone—Infection—Estradiol—prostate cancer	5.94e-05	0.00126	CcSEcCtD
Nitisinone—Convulsion—Mitoxantrone—prostate cancer	5.92e-05	0.00126	CcSEcCtD
Nitisinone—Abdominal pain—Conjugated Estrogens—prostate cancer	5.91e-05	0.00126	CcSEcCtD
Nitisinone—Hepatic failure—Epirubicin—prostate cancer	5.88e-05	0.00125	CcSEcCtD
Nitisinone—Conjunctivitis—Docetaxel—prostate cancer	5.87e-05	0.00125	CcSEcCtD
Nitisinone—Eye pain—Epirubicin—prostate cancer	5.86e-05	0.00124	CcSEcCtD
Nitisinone—Sepsis—Doxorubicin—prostate cancer	5.85e-05	0.00124	CcSEcCtD
Nitisinone—Skin disorder—Estradiol—prostate cancer	5.81e-05	0.00123	CcSEcCtD
Nitisinone—Alopecia—Etoposide—prostate cancer	5.77e-05	0.00122	CcSEcCtD
Nitisinone—Headache—Ethinyl Estradiol—prostate cancer	5.74e-05	0.00122	CcSEcCtD
Nitisinone—HPD—Metabolism—COMT—prostate cancer	5.73e-05	0.00234	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GSTP1—prostate cancer	5.7e-05	0.00233	CbGpPWpGaD
Nitisinone—Epistaxis—Docetaxel—prostate cancer	5.7e-05	0.00121	CcSEcCtD
Nitisinone—Conjunctivitis—Capecitabine—prostate cancer	5.69e-05	0.00121	CcSEcCtD
Nitisinone—Agranulocytosis—Docetaxel—prostate cancer	5.64e-05	0.0012	CcSEcCtD
Nitisinone—HPD—Metabolism—ITPR1—prostate cancer	5.61e-05	0.0023	CbGpPWpGaD
Nitisinone—Dermatitis exfoliative—Epirubicin—prostate cancer	5.6e-05	0.00119	CcSEcCtD
Nitisinone—Hepatic function abnormal—Doxorubicin—prostate cancer	5.6e-05	0.00119	CcSEcCtD
Nitisinone—Infection—Mitoxantrone—prostate cancer	5.54e-05	0.00118	CcSEcCtD
Nitisinone—Epistaxis—Capecitabine—prostate cancer	5.52e-05	0.00117	CcSEcCtD
Nitisinone—Agranulocytosis—Capecitabine—prostate cancer	5.46e-05	0.00116	CcSEcCtD
Nitisinone—Thrombocytopenia—Mitoxantrone—prostate cancer	5.46e-05	0.00116	CcSEcCtD
Nitisinone—Haemoglobin—Docetaxel—prostate cancer	5.45e-05	0.00116	CcSEcCtD
Nitisinone—Hepatic failure—Doxorubicin—prostate cancer	5.44e-05	0.00116	CcSEcCtD
Nitisinone—Haemorrhage—Docetaxel—prostate cancer	5.42e-05	0.00115	CcSEcCtD
Nitisinone—Eye pain—Doxorubicin—prostate cancer	5.42e-05	0.00115	CcSEcCtD
Nitisinone—Hypoglycaemia—Epirubicin—prostate cancer	5.42e-05	0.00115	CcSEcCtD
Nitisinone—Skin disorder—Mitoxantrone—prostate cancer	5.41e-05	0.00115	CcSEcCtD
Nitisinone—Pruritus—Goserelin—prostate cancer	5.34e-05	0.00113	CcSEcCtD
Nitisinone—Somnolence—Estradiol—prostate cancer	5.32e-05	0.00113	CcSEcCtD
Nitisinone—HPD—Metabolism—TYMS—prostate cancer	5.3e-05	0.00217	CbGpPWpGaD
Nitisinone—Pruritus—Conjugated Estrogens—prostate cancer	5.29e-05	0.00112	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	5.29e-05	0.00112	CcSEcCtD
Nitisinone—Haemoglobin—Capecitabine—prostate cancer	5.28e-05	0.00112	CcSEcCtD
Nitisinone—Haemorrhage—Capecitabine—prostate cancer	5.25e-05	0.00112	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTM1—prostate cancer	5.24e-05	0.00214	CbGpPWpGaD
Nitisinone—Dermatitis exfoliative—Doxorubicin—prostate cancer	5.19e-05	0.0011	CcSEcCtD
Nitisinone—Diarrhoea—Goserelin—prostate cancer	5.16e-05	0.0011	CcSEcCtD
Nitisinone—HPD—Metabolism—LPL—prostate cancer	5.14e-05	0.0021	CbGpPWpGaD
Nitisinone—Diarrhoea—Conjugated Estrogens—prostate cancer	5.11e-05	0.00109	CcSEcCtD
Nitisinone—Leukopenia—Etoposide—prostate cancer	5.09e-05	0.00108	CcSEcCtD
Nitisinone—Eye disorder—Docetaxel—prostate cancer	5.07e-05	0.00108	CcSEcCtD
Nitisinone—Hypoglycaemia—Doxorubicin—prostate cancer	5.01e-05	0.00106	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP1A1—prostate cancer	4.97e-05	0.00203	CbGpPWpGaD
Nitisinone—Somnolence—Mitoxantrone—prostate cancer	4.96e-05	0.00105	CcSEcCtD
Nitisinone—HPD—Metabolism—ERCC2—prostate cancer	4.93e-05	0.00202	CbGpPWpGaD
Nitisinone—Convulsion—Etoposide—prostate cancer	4.92e-05	0.00105	CcSEcCtD
Nitisinone—Dehydration—Epirubicin—prostate cancer	4.92e-05	0.00104	CcSEcCtD
Nitisinone—Eye disorder—Capecitabine—prostate cancer	4.91e-05	0.00104	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	4.89e-05	0.00104	CcSEcCtD
Nitisinone—Gastrointestinal pain—Estradiol—prostate cancer	4.89e-05	0.00104	CcSEcCtD
Nitisinone—Dry skin—Epirubicin—prostate cancer	4.85e-05	0.00103	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	4.8e-05	0.00102	CcSEcCtD
Nitisinone—Alopecia—Docetaxel—prostate cancer	4.79e-05	0.00102	CcSEcCtD
Nitisinone—Abdominal pain—Estradiol—prostate cancer	4.73e-05	0.001	CcSEcCtD
Nitisinone—Headache—Goserelin—prostate cancer	4.73e-05	0.001	CcSEcCtD
Nitisinone—Haemoglobin—Prednisone—prostate cancer	4.7e-05	0.000999	CcSEcCtD
Nitisinone—Headache—Conjugated Estrogens—prostate cancer	4.68e-05	0.000995	CcSEcCtD
Nitisinone—Gastritis—Epirubicin—prostate cancer	4.68e-05	0.000994	CcSEcCtD
Nitisinone—Haemorrhage—Prednisone—prostate cancer	4.68e-05	0.000994	CcSEcCtD
Nitisinone—Alopecia—Capecitabine—prostate cancer	4.64e-05	0.000986	CcSEcCtD
Nitisinone—HPD—Metabolism—MTHFR—prostate cancer	4.63e-05	0.00189	CbGpPWpGaD
Nitisinone—Infection—Etoposide—prostate cancer	4.61e-05	0.000978	CcSEcCtD
Nitisinone—Gastrointestinal pain—Mitoxantrone—prostate cancer	4.56e-05	0.000968	CcSEcCtD
Nitisinone—Dehydration—Doxorubicin—prostate cancer	4.55e-05	0.000967	CcSEcCtD
Nitisinone—HPD—Metabolism—PPARA—prostate cancer	4.54e-05	0.00186	CbGpPWpGaD
Nitisinone—Thrombocytopenia—Etoposide—prostate cancer	4.54e-05	0.000964	CcSEcCtD
Nitisinone—Skin disorder—Etoposide—prostate cancer	4.5e-05	0.000957	CcSEcCtD
Nitisinone—Dry skin—Doxorubicin—prostate cancer	4.48e-05	0.000953	CcSEcCtD
Nitisinone—Abdominal pain—Mitoxantrone—prostate cancer	4.41e-05	0.000936	CcSEcCtD
Nitisinone—Bronchitis—Epirubicin—prostate cancer	4.4e-05	0.000934	CcSEcCtD
Nitisinone—Eye disorder—Prednisone—prostate cancer	4.37e-05	0.000928	CcSEcCtD
Nitisinone—Gastritis—Doxorubicin—prostate cancer	4.33e-05	0.00092	CcSEcCtD
Nitisinone—HPD—Metabolism—CAV1—prostate cancer	4.27e-05	0.00175	CbGpPWpGaD
Nitisinone—Pruritus—Estradiol—prostate cancer	4.23e-05	0.000899	CcSEcCtD
Nitisinone—Leukopenia—Docetaxel—prostate cancer	4.23e-05	0.000898	CcSEcCtD
Nitisinone—Alopecia—Prednisone—prostate cancer	4.13e-05	0.000878	CcSEcCtD
Nitisinone—Somnolence—Etoposide—prostate cancer	4.12e-05	0.000876	CcSEcCtD
Nitisinone—Diarrhoea—Estradiol—prostate cancer	4.09e-05	0.000869	CcSEcCtD
Nitisinone—Leukopenia—Capecitabine—prostate cancer	4.09e-05	0.000869	CcSEcCtD
Nitisinone—Convulsion—Docetaxel—prostate cancer	4.09e-05	0.000869	CcSEcCtD
Nitisinone—Bronchitis—Doxorubicin—prostate cancer	4.07e-05	0.000864	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	3.99e-05	0.000848	CcSEcCtD
Nitisinone—Conjunctivitis—Epirubicin—prostate cancer	3.96e-05	0.000841	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CG—prostate cancer	3.89e-05	0.00159	CbGpPWpGaD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	3.87e-05	0.000821	CcSEcCtD
Nitisinone—Epistaxis—Epirubicin—prostate cancer	3.84e-05	0.000816	CcSEcCtD
Nitisinone—Infection—Docetaxel—prostate cancer	3.83e-05	0.000813	CcSEcCtD
Nitisinone—Diarrhoea—Mitoxantrone—prostate cancer	3.81e-05	0.00081	CcSEcCtD
Nitisinone—Agranulocytosis—Epirubicin—prostate cancer	3.8e-05	0.000808	CcSEcCtD
Nitisinone—Gastrointestinal pain—Etoposide—prostate cancer	3.79e-05	0.000805	CcSEcCtD
Nitisinone—Thrombocytopenia—Docetaxel—prostate cancer	3.77e-05	0.000801	CcSEcCtD
Nitisinone—Headache—Estradiol—prostate cancer	3.75e-05	0.000796	CcSEcCtD
Nitisinone—Skin disorder—Docetaxel—prostate cancer	3.74e-05	0.000795	CcSEcCtD
Nitisinone—Agitation—Prednisone—prostate cancer	3.74e-05	0.000795	CcSEcCtD
Nitisinone—Infection—Capecitabine—prostate cancer	3.71e-05	0.000787	CcSEcCtD
Nitisinone—HPD—Metabolism—INS—prostate cancer	3.68e-05	0.00151	CbGpPWpGaD
Nitisinone—Haemoglobin—Epirubicin—prostate cancer	3.68e-05	0.000781	CcSEcCtD
Nitisinone—Abdominal pain—Etoposide—prostate cancer	3.67e-05	0.000779	CcSEcCtD
Nitisinone—Conjunctivitis—Doxorubicin—prostate cancer	3.67e-05	0.000778	CcSEcCtD
Nitisinone—Haemorrhage—Epirubicin—prostate cancer	3.66e-05	0.000777	CcSEcCtD
Nitisinone—Thrombocytopenia—Capecitabine—prostate cancer	3.65e-05	0.000776	CcSEcCtD
Nitisinone—Skin disorder—Capecitabine—prostate cancer	3.62e-05	0.00077	CcSEcCtD
Nitisinone—HPD—Metabolism—CREBBP—prostate cancer	3.61e-05	0.00148	CbGpPWpGaD
Nitisinone—Epistaxis—Doxorubicin—prostate cancer	3.56e-05	0.000755	CcSEcCtD
Nitisinone—Convulsion—Prednisone—prostate cancer	3.53e-05	0.000749	CcSEcCtD
Nitisinone—Agranulocytosis—Doxorubicin—prostate cancer	3.52e-05	0.000747	CcSEcCtD
Nitisinone—Headache—Mitoxantrone—prostate cancer	3.49e-05	0.000742	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.44e-05	0.000731	CcSEcCtD
Nitisinone—Somnolence—Docetaxel—prostate cancer	3.43e-05	0.000728	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CD—prostate cancer	3.42e-05	0.0014	CbGpPWpGaD
Nitisinone—Eye disorder—Epirubicin—prostate cancer	3.42e-05	0.000726	CcSEcCtD
Nitisinone—Haemoglobin—Doxorubicin—prostate cancer	3.4e-05	0.000723	CcSEcCtD
Nitisinone—Haemorrhage—Doxorubicin—prostate cancer	3.38e-05	0.000719	CcSEcCtD
Nitisinone—Infection—Prednisone—prostate cancer	3.3e-05	0.000701	CcSEcCtD
Nitisinone—Pruritus—Etoposide—prostate cancer	3.28e-05	0.000697	CcSEcCtD
Nitisinone—Alopecia—Epirubicin—prostate cancer	3.23e-05	0.000687	CcSEcCtD
Nitisinone—HPD—Metabolism—NOS3—prostate cancer	3.23e-05	0.00132	CbGpPWpGaD
Nitisinone—Skin disorder—Prednisone—prostate cancer	3.23e-05	0.000686	CcSEcCtD
Nitisinone—Diarrhoea—Etoposide—prostate cancer	3.17e-05	0.000674	CcSEcCtD
Nitisinone—Eye disorder—Doxorubicin—prostate cancer	3.16e-05	0.000672	CcSEcCtD
Nitisinone—Gastrointestinal pain—Docetaxel—prostate cancer	3.15e-05	0.000669	CcSEcCtD
Nitisinone—Tension—Epirubicin—prostate cancer	3.13e-05	0.000664	CcSEcCtD
Nitisinone—Nervousness—Epirubicin—prostate cancer	3.09e-05	0.000657	CcSEcCtD
Nitisinone—Gastrointestinal pain—Capecitabine—prostate cancer	3.05e-05	0.000648	CcSEcCtD
Nitisinone—Abdominal pain—Docetaxel—prostate cancer	3.05e-05	0.000647	CcSEcCtD
Nitisinone—Alopecia—Doxorubicin—prostate cancer	2.99e-05	0.000635	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CB—prostate cancer	2.98e-05	0.00122	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PTGS2—prostate cancer	2.95e-05	0.00121	CbGpPWpGaD
Nitisinone—Abdominal pain—Capecitabine—prostate cancer	2.95e-05	0.000626	CcSEcCtD
Nitisinone—Agitation—Epirubicin—prostate cancer	2.93e-05	0.000622	CcSEcCtD
Nitisinone—Headache—Etoposide—prostate cancer	2.9e-05	0.000617	CcSEcCtD
Nitisinone—Tension—Doxorubicin—prostate cancer	2.89e-05	0.000614	CcSEcCtD
Nitisinone—Nervousness—Doxorubicin—prostate cancer	2.86e-05	0.000608	CcSEcCtD
Nitisinone—Leukopenia—Epirubicin—prostate cancer	2.85e-05	0.000605	CcSEcCtD
Nitisinone—Convulsion—Epirubicin—prostate cancer	2.76e-05	0.000586	CcSEcCtD
Nitisinone—Pruritus—Docetaxel—prostate cancer	2.73e-05	0.000579	CcSEcCtD
Nitisinone—Gastrointestinal pain—Prednisone—prostate cancer	2.72e-05	0.000577	CcSEcCtD
Nitisinone—Agitation—Doxorubicin—prostate cancer	2.71e-05	0.000575	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.69e-05	0.000572	CcSEcCtD
Nitisinone—Pruritus—Capecitabine—prostate cancer	2.64e-05	0.000561	CcSEcCtD
Nitisinone—Leukopenia—Doxorubicin—prostate cancer	2.64e-05	0.00056	CcSEcCtD
Nitisinone—Diarrhoea—Docetaxel—prostate cancer	2.64e-05	0.00056	CcSEcCtD
Nitisinone—Abdominal pain—Prednisone—prostate cancer	2.63e-05	0.000558	CcSEcCtD
Nitisinone—Infection—Epirubicin—prostate cancer	2.58e-05	0.000548	CcSEcCtD
Nitisinone—HPD—Metabolism—PTEN—prostate cancer	2.58e-05	0.00105	CbGpPWpGaD
Nitisinone—Convulsion—Doxorubicin—prostate cancer	2.55e-05	0.000542	CcSEcCtD
Nitisinone—Diarrhoea—Capecitabine—prostate cancer	2.55e-05	0.000542	CcSEcCtD
Nitisinone—Thrombocytopenia—Epirubicin—prostate cancer	2.54e-05	0.000541	CcSEcCtD
Nitisinone—Skin disorder—Epirubicin—prostate cancer	2.52e-05	0.000536	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.49e-05	0.000529	CcSEcCtD
Nitisinone—HPD—Metabolism—EP300—prostate cancer	2.46e-05	0.00101	CbGpPWpGaD
Nitisinone—Headache—Docetaxel—prostate cancer	2.41e-05	0.000513	CcSEcCtD
Nitisinone—Infection—Doxorubicin—prostate cancer	2.39e-05	0.000507	CcSEcCtD
Nitisinone—Thrombocytopenia—Doxorubicin—prostate cancer	2.35e-05	0.0005	CcSEcCtD
Nitisinone—Pruritus—Prednisone—prostate cancer	2.35e-05	0.000499	CcSEcCtD
Nitisinone—Headache—Capecitabine—prostate cancer	2.34e-05	0.000496	CcSEcCtD
Nitisinone—Skin disorder—Doxorubicin—prostate cancer	2.34e-05	0.000496	CcSEcCtD
Nitisinone—Somnolence—Epirubicin—prostate cancer	2.31e-05	0.000491	CcSEcCtD
Nitisinone—Diarrhoea—Prednisone—prostate cancer	2.27e-05	0.000483	CcSEcCtD
Nitisinone—Somnolence—Doxorubicin—prostate cancer	2.14e-05	0.000454	CcSEcCtD
Nitisinone—Gastrointestinal pain—Epirubicin—prostate cancer	2.13e-05	0.000451	CcSEcCtD
Nitisinone—Headache—Prednisone—prostate cancer	2.08e-05	0.000442	CcSEcCtD
Nitisinone—Abdominal pain—Epirubicin—prostate cancer	2.05e-05	0.000436	CcSEcCtD
Nitisinone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.97e-05	0.000418	CcSEcCtD
Nitisinone—Abdominal pain—Doxorubicin—prostate cancer	1.9e-05	0.000404	CcSEcCtD
Nitisinone—Pruritus—Epirubicin—prostate cancer	1.84e-05	0.000391	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CA—prostate cancer	1.82e-05	0.000744	CbGpPWpGaD
Nitisinone—Diarrhoea—Epirubicin—prostate cancer	1.78e-05	0.000378	CcSEcCtD
Nitisinone—Pruritus—Doxorubicin—prostate cancer	1.7e-05	0.000361	CcSEcCtD
Nitisinone—Diarrhoea—Doxorubicin—prostate cancer	1.65e-05	0.000349	CcSEcCtD
Nitisinone—Headache—Epirubicin—prostate cancer	1.63e-05	0.000346	CcSEcCtD
Nitisinone—Headache—Doxorubicin—prostate cancer	1.51e-05	0.00032	CcSEcCtD
Nitisinone—HPD—Metabolism—AKT1—prostate cancer	1.48e-05	0.000607	CbGpPWpGaD
